Patent Term Extension for Drugs Not Limited to New Chemical Entities

Published date03 May 2017
Law FirmTroutman Pepper
AuthorN. Nicole Stakleff,Kyle Dolinsky
Subject MatterUSPTO,Medical Devices,FDA,Patents,Prescription Drugs,Biologics,Patent Term Extensions,Investigational New Drug procedures (IND),Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT